Clinical Research Informer

Grand Rounds March 3, 2023: Adoption, Implementation and Sustainment of Family-focused Prevention in Health Care Systems: How Do We Get There? (Margaret Kuklinski, PhD; Stacy Sterling, DrPH, MSW)

Rethinking Clinical Trials

JULY 14, 2023

Tags #pctGR, @Collaboratory1 The post Grand Rounds March 3, 2023: Adoption, Implementation and Sustainment of Family-focused Prevention in Health Care Systems: How Do We Get There? I was surprised and pleased by how well the virtual adaption went. It was a huge amount of work during the scary time of the beginning of COVID.

Clinical Trials

Clinical Trials Clinical Trials Trials Research

AAIC 2021: Six Ways the Approval of Aducanumab Will Change Alzheimer’s Clinical Trials

XTalks

AUGUST 23, 2021

Grill, PhD, a professor of psychiatry and human behavior in the School of Medicine at UC Irvine. With a $56,000 price tag for a year’s worth of treatment, Aduhelm is far from the most expensive drug on the market. While it is a milestone, it is not the end of a journey.

Clinical Trials

Clinical Trials Clinical Trials Trials Drugs

Viagra ‘should be tested as Alzheimer’s therapy’

pharmaphorum

DECEMBER 7, 2021

That finding could provide some comfort to Biogen and Eisai, whose recently-approved amyloid-targeting drug Aduhelm (aducanumab) is struggling to gain traction in the market on the back of unconvincing efficacy data, safety concerns and a high price tag.

Drugs

Drugs Clinical Trials Clinical Trials Scientist

Grand Rounds March 3, 2023: Adoption, Implementation and Sustainment of Family-focused Prevention in Health Care Systems: How Do We Get There? (Margaret Kuklinski, PhD; Stacy Sterling, DrPH, MSW)

AAIC 2021: Six Ways the Approval of Aducanumab Will Change Alzheimer’s Clinical Trials

Viagra ‘should be tested as Alzheimer’s therapy’

Stay Connected